Mf. Pilkington et al., WORTMANNIN INHIBITS SPREADING AND CHEMOTAXIS OF RAT OSTEOCLASTS IN IN-VITRO, Journal of bone and mineral research, 13(4), 1998, pp. 688-694
Wortmannin (WT) and 17 beta-hydroxywortmannin (HWT), which are inhibit
ors of phosphatidylinositol-3(OH)-kinase (PI3K), have been shown previ
ously to inhibit bone resorption in vitro and in vivo, possibly by int
erfering with formation of th osteoclast ruffled border. Since migrati
on of osteoclasts also plays an important role in the process of bone
resorption, we investigated the effects of these inhibitors on osteocl
ast morphology and motility. Both HWT and WT caused a sustained decrea
se in the planar area of osteoclasts in vitro (half maximal effect at
25 and 165 nM, respectively), with the effect of HWT on cell area more
readily reversible than WT. These agents also caused accumulation of
intracellular vesicles. Time-lapse video microscopy was used to record
the migration of osteoclasts in response to macrophage colony-stimula
ting factor (M-CSF) or vehicle, flowing passively from a micropipette
positioned 200-400 mu m from the cell. M-CSF caused directed migration
of osteoclasts, indicating chemotaxis (over 3 h osteoclasts migrated
96 +/- 14 mu m in response to M-CSF vs. 11 +/- 2 mu m in control exper
iments). Both WT (100 or 500 nM) and LY294002 (100 mu M), a specific P
I3K inhibitor structurally unrelated to WT, significantly inhibited os
teoclast chemotaxis in response to M-CSF. Taken together, these effect
s of WT, HWT, and LY294002 are consistent with an important role for P
I3K in regulating cytoskeletal function in osteoclasts. The inhibitory
effects of WT and HWT on bone resorption may be due, in part, to impa
irment of osteoclast motility.